...
首页> 外文期刊>Diagnostic cytopathology >Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features
【24h】

Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features

机译:流式细胞术免疫渗透性玻璃体标本对淋巴瘤的诊断无需支持形态特征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Diagnostic vitrectomy with flow cytometry immunophenotyping (FCI) is being increasingly used as part of screening for diagnostically challenging cases. We aim to evaluate the utility of combined cytopathology and FCI in diagnostic pars plana vitrectomy. We also aim to evaluate cytologic features that could potentially predict FCI outcomes. This study provides clearer indications for use of FCI in diagnostic vitrectomy. Methods A case series of diagnostic pars plana vitrectomy specimens from 2010 to 2016 from a single institution was retrospectively evaluated. Associations between cytologic features and FCI were analyzed statistically. Results Ninety‐nine vitrectomy specimens (90 patients) were evaluated. Evaluation was diagnostic in 39 of 99 (39.4%) specimens. FCI was performed in 66 of 73 (90.4%) specimens collected for lymphoma indication, and 9 of those 66 FCIs (13.6%) demonstrated abnormal lymphocytes. FCI was performed in 10 of 26 (38.5%) specimens collected for non‐lymphomatous indications; all 10 FCIs failed to demonstrate lymphocyte abnormality. The absence of large lymphocytes frequently demonstrated negative FCI (negative predictive value?=?97.7%), and was the sole cytologic feature significantly associated with a negative FCI result [OR, 14.0; 95% CI, 1.65‐635.6; P ?=?.034]. Conclusions Diagnostic vitrectomy with cytopathology evaluation is valuable, and concomitant FCI is useful to confirm intraocular lymphoma. However, the absence of large lymphocytes on cytologic examination is the single significant predictor of a negative FCI, and this finding should preclude the use of FCI.
机译:背景技术具有流式细胞术免疫蛋白型(FCI)的诊断蒸发术(FCI)越来越多地用作诊断挑战性案件的筛选的一部分。我们的目标是评估组合细胞病理学和FCI在诊断Pars Parala Vectomy中的效用。我们还可以评估可能预测FCI结果的细胞学特征。本研究提供了用于在诊断玻璃切除术中使用FCI的更清晰的指示。方法回顾性评估从单一机构2010年到2016年诊断Para vitrectomy标本的案例系列。统计上分析了细胞学特征和FCI之间的关联。结果评价九十九个玻璃体切除标本(90例)。评估在99(39.4%)标本中的39例诊断。 FCI在收集的73个(90.4%)标本中进行的66个,用于淋巴瘤指示,其中9种66个FCIS(13.6%)显示出异常的淋巴细胞。 FCI在收集的非淋巴瘤适应症中的10个(38.5%)标本中进行;所有10个FCI都未能证明淋巴细胞异常。没有大的淋巴细胞经常展示阴性FCI(阴性预测值?= 97.7%),并且是与阴性FCI结果显着相关的唯一细胞学特征[或14.0; 95%CI,1.65-635.6; p?= ?. 034]。结论缩细胞病理学评价的诊断蒸发术是有价值的,并且伴随的FCI可用于确认眼内淋巴瘤。然而,在细胞学检查上没有大淋巴细胞是阴性FCI的单一显着预测因子,这种发现应该排除使用FCI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号